Dossier
H.I.V. prevention pill
Coverage of H.I.V. prevention pill in the Nexus archive.
- With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is taking steps to ensure access to a new H.I.V. prevention pill. Health workers at the University of Zambia in Lusaka are engaging students about H.I.V. prevention drugs.
- STAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Merck has entered voluntary royalty-free licensing deals with seven companies to produce generic versions of an experimental HIV prevention pill, alimatravir, in 129 low- and middle-income countries. The agreement allows manufacturers in Africa and India to supply the drug to public and private buyers, aiming to expand access while the medicine undergoes late-stage clinical trials.